Skip to Content
Morningstar
Get 14 Days Free

Reliv' International Inc RELV

Morningstar Rating
Rating as of

Morningstar’s Analysis

There is no Morningtar’s Analysis data available.

Company Profile

Business Description

Reliv' International Inc is a developer, manufacturer, and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. The company sells its products throughout the United States, Australia, Canada, Mexico, Europe, and Asia through an international network marketing system using independent distributors. It generates a majority of its revenue from the United States.

Contact
136 Chesterfield Industrial Boulevard
Chesterfield, MO, 63005
T +1 636 537-9715
Sector Consumer Defensive
Industry Packaged Foods
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2021
Stock Type Distressed
Employees 91

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.